PATENT CLAIM ANALYSIS

Application Number: 16202207
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-03
Patent Classification: ["514", "230500"]

Abstract:
The present invention provides methods and uses of inhibitors of histone deacetylase 11 (HDAC11) in the treatment of diseases and/or disorders, such as, for example, cell proliferative diseases.

Claim (Index 7):
The compound of  claim 6 , wherein R 6  is H.

Metadata:
- Claim Count in Document: 15.0
- Percentile: 98.0
- Lexical Diversity: 1.17241
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['16202210', '11687565', '13683880', '15321410', '15234412']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8176468730607155
- 35 USC 102 Novelty (BERT): 0.6332987321753745
- Combined Prediction Score: 0.7992120589721814
- Mean Citation Score: 420.497506
- Max Citation Score: 690.6786
- Similarity Product: 524.5168971947193

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test